{"schema_version":"secwatch.filing_event.v1","accession":"0000950170-24-117727","form_type":"8-K","ticker":"TMDX","cik":"0001756262","company_name":"TransMedics Group, Inc.","filed_at":"2024-10-28T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.483535+00:00","generated_at":"2026-05-30T09:46:10.180767+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"TransMedics Q3 revenue $108.8M (+64% YoY), net income $4.2M; FY guidance reaffirmed","bullets":["Total revenue $108.8M, up 64% from $66.4M in Q3 2023.","Net income $4.2M ($0.12 diluted EPS) vs net loss of $25.4M in prior year.","Gross margin 56% vs 61% a year ago due to shift to service revenue.","FY 2024 revenue guidance reaffirmed at $425M–$445M (76–84% growth).","Cash $330.1M as of Sep 30; owned 18 aircraft for the National OCS Program."],"urls":{"canonical":"https://secwatch.observer/filing/0000950170-24-117727","json":"https://secwatch.observer/filing/0000950170-24-117727.json","markdown":"https://secwatch.observer/filing/0000950170-24-117727.md","text":"https://secwatch.observer/filing/0000950170-24-117727.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024117727/0000950170-24-117727-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1756262/000095017024117727/tmdx-20241028.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T09:46:10.180767+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}